Literature DB >> 30458283

Hippocampal orexin receptor blocking prevented the stress induced social learning and memory deficits.

Saeedeh Bahramzadeh Zoeram1, Mahmoud Elahdadi Salmani2, Taghi Lashkarbolouki1, Iran Goudarzi1.   

Abstract

Stress as a homeostatic challenge leads to the malfunction of learning and memory processes, namely social learning and memory. The orexin system is involved in stress responses through connections to the hypothalamic-pituitary axis (HPA). In addition, the hippocampus, a structure vulnerable to stress-induced changes, expresses orexin receptors 1 and 2 (OXr1 and OXr2) in various sub-regions. The present study is aimed at assessing the effects of hippocampal orexin receptor blockade on social learning and memory impairments and anxiety development following stress. Male Wistar rats (220-250 g) underwent cannula implantation in the hippocampus. Acute (two mild electric shocks, 5.5 mA) and chronic stresses (ten days of restraint, 6 h daily) were applied with or without injection of orexin receptor antagonists (SB-334867 or TCS OX 29). Sociability and social novelty in animals were assessed in a three-chamber social maze at the end of stress application. Anxiety and exploratory behavior of animals were then examined, with 20 min intervals, using the open field (OF) and elevated plus maze (EPM) tests, respectively. Cisterna Magna cerebro-spinal fluid (CSF) was drained, before sacrifice, for orexin (OX) assay and trunk blood was collected to measure the plasma corticosterone (CRT). Neither the acute nor the chronic stress could affect the sociability. The acute but not chronic stress prevented the animal from sniffing the familiar caged rat in the novelty session, a response which was reversed following the blockade of both OXRs. Furthermore, acute but not chronic stress, led to increased anxiety and immobility behavior which were both impeded by blocking the orexin receptor (OXR). Conversely, OX content in CSF increased due to chronic restraint stress, an effect that was reversed by orexin blockade. Finally, elevated plasma CRT was recorded in response to both acute and chronic stresses. The observed increase in plasma CRT in chronically-stressed rats was abolished following inhibition of OXRs, however a similar effect was not seen in the acute-stress group. Our results identify hippocampal OXRs as potential candidates capable of preventing acute stress-induced impairments of social novelty and anxiety behavior, and chronic stress-induced plasma CRT and CSF orexin, changes. OXR manipulation may improve adaptation to stress pathophysiology.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Hippocampus; Orexin receptors; Social novelty; Stress

Mesh:

Substances:

Year:  2018        PMID: 30458283     DOI: 10.1016/j.nlm.2018.11.009

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  4 in total

1.  Chronic clomipramine treatment increases hippocampal volume in rats exposed to chronic unpredictable mild stress.

Authors:  Shanshan Zhang; Juntao Hu; Guixue Liu; Haoran Wu; Meihui Li; Chenye Shi; Qiong Liu; Wensheng Li
Journal:  Transl Psychiatry       Date:  2022-06-10       Impact factor: 7.989

Review 2.  Research progress on the mechanism of orexin in pain regulation in different brain regions.

Authors:  Xianhui Kang; Hongli Tang; Yao Liu; Yan Yuan; Mi Wang
Journal:  Open Life Sci       Date:  2021-01-20       Impact factor: 0.938

3.  Electroacupuncture Enhances Neuroplasticity by Regulating the Orexin A-Mediated cAMP/PKA/CREB Signaling Pathway in Senescence-Accelerated Mouse Prone 8 (SAMP8) Mice.

Authors:  Zhitao Hou; Xinyu Yang; Yang Li; Jing Chen; Hongcai Shang
Journal:  Oxid Med Cell Longev       Date:  2022-02-04       Impact factor: 6.543

4.  Under or Absent Reporting of Light Stimuli in Testing of Anxiety-Like Behaviors in Rodents: The Need for Standardization.

Authors:  Lorenz S Neuwirth; Michael T Verrengia; Zachary I Harikinish-Murrary; Jessica E Orens; Oscar E Lopez
Journal:  Front Mol Neurosci       Date:  2022-08-17       Impact factor: 6.261

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.